RadNet, Inc. (RDNT)
69.12
-1.29
(-1.83%)
USD |
NASDAQ |
Oct 16, 14:38
RadNet Cash from Investing (Quarterly) : -63.55M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -63.55M |
| March 31, 2026 | -370.97M |
| December 31, 2025 | -113.94M |
| September 30, 2025 | -75.72M |
| June 30, 2025 | -95.06M |
| March 31, 2025 | -56.75M |
| December 31, 2024 | -34.02M |
| September 30, 2024 | -42.58M |
| June 30, 2024 | -77.34M |
| March 31, 2024 | -56.77M |
| December 31, 2023 | -43.53M |
| September 30, 2023 | -46.91M |
| June 30, 2023 | -40.35M |
| March 31, 2023 | -65.56M |
| December 31, 2022 | -123.90M |
| September 30, 2022 | -27.06M |
| June 30, 2022 | -34.42M |
| March 31, 2022 | -61.56M |
| December 31, 2021 | -62.00M |
| September 30, 2021 | -39.85M |
| June 30, 2021 | -32.31M |
| March 31, 2021 | -87.35M |
| December 31, 2020 | -37.96M |
| September 30, 2020 | -20.68M |
| June 30, 2020 | -12.54M |
| Date | Value |
|---|---|
| March 31, 2020 | -55.06M |
| December 31, 2019 | -5.484M |
| September 30, 2019 | -17.14M |
| June 30, 2019 | -41.65M |
| March 31, 2019 | -29.17M |
| December 31, 2018 | -62.51M |
| September 30, 2018 | -20.70M |
| June 30, 2018 | -31.25M |
| March 31, 2018 | -29.85M |
| December 31, 2017 | -13.51M |
| September 30, 2017 | -16.97M |
| June 30, 2017 | -8.50M |
| March 31, 2017 | -33.97M |
| December 31, 2016 | -5.277M |
| September 30, 2016 | -12.83M |
| June 30, 2016 | -19.74M |
| March 31, 2016 | -27.80M |
| December 31, 2015 | -58.15M |
| September 30, 2015 | 27.47M |
| June 30, 2015 | -46.50M |
| March 31, 2015 | -19.62M |
| December 31, 2014 | -9.728M |
| September 30, 2014 | -14.41M |
| June 30, 2014 | -11.31M |
| March 31, 2014 | -18.19M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Castle Biosciences, Inc. | -15.96M |
| Lumexa Imaging Holdings, Inc. | -13.64M |
| Quest Diagnostics, Inc. | -134.00M |
| Labcorp Holdings, Inc. | -366.20M |
| OPKO Health, Inc. | 15.54M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 94.10M |
| Cash from Financing (Quarterly) | 240.22M |
| Free Cash Flow | 72.37M |
| Free Cash Flow Per Share (Quarterly) | 0.4803 |
| Free Cash Flow to Equity (Quarterly) | -211.86M |
| Free Cash Flow to Firm (Quarterly) | 51.63M |
| Free Cash Flow Yield | 1.35% |